To further identify the mechanisms involved in the increased modulation of catecholamine secretion observed in 3xTg CCs that occurs with AD progression, we decided to study possible changes in the two main elements involved in ATP-induced modulation, i.e., the purinergic receptors and the VDCCs. This evidence concerns the gene P2RX4 and Alzheimer disease.